Background Given the large number of interventions of uncertain effectiveness, research on communicating uncertainty is needed to examine its impact on patientsÕ health decisions.
There has been a growing body of research on communicating risks and benefits of treatment options to patients (e.g. [1] [2] [3] ) for informed or shared decision making. The goal of shared decision-making is to improve patientsÕ decisionmaking process, and to match patientsÕ intervention choices with their preferences for the benefits and harms of intervention options. 4 Experts assert that shared decision making is essential when there are no clear standards of care or guidelines for patientsÕ treatment decisions, and when patientsÕ preferences for risks and benefits of interventions influence choices. 4, 5 Most medical decisions are complicated by uncertain or unknown evidence about risk ⁄ benefit information. 6 However, little is known about how to communicate this scientific uncertainty (the quality of risk information) to patients, 7 including uncertainty about statistical risk (e.g. wide confidence intervals), and uncertainty about the strength and quality of available evidence used to make health decisions. Physicians are often hesitant to communicate uncertainty to patients, 8 despite the prevalence of uncertainty in medical decisions. Some physicians have been trained to accept and manage uncertainty internally, and provide a confident recommendation to patients as they guide them in clinical decisions. 9 Physicians may also believe that communicating the complexity of uncertainty will overwhelm and confuse patients. 10 Full disclosure of scientific uncertainty in addition to discussion of options could actually impair patientsÕ ability to make informed decisions, particularly for those with lower numeracy skills. [11] [12] [13] Some patients also avoid statistical uncertainty (Ôambiguity aversionÕ) and defer or reject decision-making as a result. 12, 14 Thus it remains unclear whether communicating scientific uncertainty about risks and benefits aids patientsÕ decision making. Communicating scientific uncertainty could affect patientsÕ decision satisfaction. For instance, some patients such as those who are older do not always want to participate in decisions involving estimates of probabilities. 15, 16 Patients with lower numeracy skills might also feel less comfortable with the amount of information required to understand scientific uncertainty and make informed decisions. 11 For these patients, discussing scientific uncertainty with their physician could lead to confusion and lower decision satisfaction. However, others report that acknowledging scientific uncertainty is more trustworthy and reflects the true nature of medical decisions; 1 patients with these beliefs could feel more satisfied and comfortable with their decisions after discussing scientific uncertainty with their physicians. Given the increasing focus on shared decision making, and the large number of interventions of unknown or uncertain effectiveness, research on communicating scientific uncertainty is needed to examine the impact of uncertainty on patientsÕ clinical decisions. The proposed study was developed to examine patient-physician communication of scientific uncertainty and its impact on decisions about surgery and decision satisfaction among women seen in a breast health centre. The study aims were to: (i) explore the relationship between communication about uncertainty and patientsÕ surgical decisions and decision satisfaction and (ii) explore whether demographic variables, cancer disease status, or patientsÕ numeracy moderate the relationship between physiciansÕ communication and patientsÕ decisions about surgery and decision satisfaction.
Method
Women were recruited from a breast health centre in Providence, RI. Physicians identified women who would be facing a decision about surgery that involved uncertainty, where there were multiple options available and patient preferences might dictate intervention choices. These patients would be presented with two or more intervention options with no clear ÔbestÕ choice based on outcome evidence. For instance, women could be deciding on a lumpectomy or mastectomy for multiple small tumours in the same breast quadrant, or could be deciding on surgery vs. active screening for multiple areas of atypical hyperplasia.
Recruitment occurred between February and September 2008. A total of 80 women were eligible and approached about the study; 75 agreed to participate (94% response rate). Women were asked whether the researcher could observe their appointment, whether they would complete a survey after their appointment, and whether they would complete a follow-up survey about their decision making process 1-2 weeks later by telephone. Participants were paid $10 at the time of their appointment for participating. With their consent, womenÕs decisions were verified through their medical charts. PatientsÕ choices were compared with either the multidisciplinary tumour boardÕs recommendation (when applicable), or their physicianÕs recommendation as documented in the medical chart. The institutional review boards of the academic institution and affiliated hospitals approved this study.
Measures

Participant characteristics
Participants were asked questions about their age, race, ethnicity, education, income and medical history.
Decision communication
Decision communication was measured using the OPTION scale, 17, 18 an observational measure of the degree to which physicians involve patients in decision-making. We added three items to the OPTION scale to measure communication of uncertainty: ÔThe clinician discusses stochastic uncertainty (the notion of chance),Õ ÔThe clinician discusses probabilistic uncertainty (uncertainty about risk estimates, e.g. CIs)Õ, and ÔThe clinician discusses evidentiary uncertainty (uncertainty about strength or quality of the evidence in the literature).Õ These items were scored in the same manner as the original scale items (from 0 to 4), and the mean was translated into a score out of 100 as scored in the original OPTION items. Higher scores on these added items indicated a better communication of uncertainty in ways defined by the international experts in risk communication (e.g. 2, 4, 5 ) as there are no standards for communicating scientific uncertainty at this time. 7 For instance, for probabilistic uncertainty, higher scores were coded if physicians communicated a range of frequencies or percentages (e.g. Ôapproximately 20-25% of women just like you…Õ). Lower scores were coded if physicians used general qualitative descriptors such as Ôa small number of women…Õ or Ôin our best estimate, most women…Õ For evidentiary uncertainty, higher scores were coded if physicians referred to literature or clinical guidelines when discussing uncertainty, with more and clearer detail indicating higher scores.
Reactions to uncertainty
The revised PhysiciansÕ Reaction to Uncertainty Scale 19,20 is a 15-item scale that measures attitudes towards uncertainty in medical practice in four areas: anxiety from uncertainty, concern about bad outcomes, reluctance to disclose uncertainty to patients and reluctance to disclose mistakes to physicians. Physicians completed this scale at the end of the study. We also adapted the anxiety from uncertainty subscale for patients to assess how patients respond to uncertainty in medicine, using parallel items (CronbachÕs alpha = 0.80).
Numeracy
PatientsÕ ability to comprehend statistical information was measured using the Subjective Numeracy Scale, 21, 22 an 8-item scale that asks patients to rate their numerical ability and preference for hearing statistical information. This scale has been correlated with actual numeric ability, and has the advantage that it does not require patients to perform mathematical calculations.
Decision satisfaction
Patients were asked to rate their satisfaction with the decision making process approximately 1 week following their appointment on a 6-point scale from not at all satisfied (1) to extremely satisfied (6), per previous studies using singleitem measures (e.g. 23 ).
Data analysis
Three dependent variables were used in the analysis. PatientsÕ surgical choice was dichotomized in two ways: (i) consistent vs. inconsistent with the physicianÕs or multidisciplinary teamsÕ recommendations for treatment, as documented in the medical chart (e.g. if a patientÕs choice deviated from any of the multiple suggested options presented to her, the choice was coded as ÔinconsistentÕ; for instance, one patient chose to have a partial mastectomy when presented a choice between a total mastectomy or neoadjuvant chemotherapy before surgery) and (ii) more vs. less aggressive choice as verified by the physicianÕs or multidisciplinary teamÕs recommendations in the medical chart (e.g. one patient chose not to have chemotherapy when presented with a choice; that choice was coded Ôless aggressiveÕ of the options presented). PatientsÕ decision satisfaction was also dichotomized into highly satisfied vs. otherwise because most patients tended to report values on the higher end of the scale (e.g. 3-6). We asked patients to rate their decision satisfaction after making a decision, but before surgery so the surgical outcome would not bias their satisfaction. We expected that most would report high levels of satisfaction soon after a choice was made, and we were interested in examining those who were not fully satisfied at that time. The explanatory variables included the measure of quality of physiciansÕ decision communication (modelled on a continuous scale using the OPTION scale total score from the original 12 items, and uncertainty score from the three added items).
PatientsÕ disease status (modelled as a binary variable, cancer diagnosis vs. no cancer diagnosis), ability subscale on the Subjective Numeracy Scale and demographic variables were explored as possible moderator effects of the relationship between decision communication and patientsÕ decision satisfaction, and decision communication and patientsÕ choice. We fitted a generalized linear mixed effects model (GLMM) to the data. Since the dependent variables were binary, we explored logit, probit, log-log and complementary log-log link functions for relating the probability of a highly satisfied response to the explanatory variables. We then replicated the analyses for the other dependent measures of consistent vs inconsistent choice, and a more vs. less aggressive choice compared with physiciansÕ recommendations as documented in medical charts.
It is possible that participants assigned to the same physician had similar responses (e.g. patients of one physician might be more satisfied than those of another physician, or might choose similar treatments). This potential clustering in the data was modelled by introducing physician-specific random effects into the model. We fit models with random effects in the intercept and the parameters corresponding to the explanatory variables. Parameters in the GLMM were estimated using maximum likelihood algorithms and the generalized estimating equations (GEE; 24, 25 ), following appropriate adjustments on the correlation structure for binary data. 26 Tests of significance were performed using the asymptotic normal distributions of the parameter estimators. SAS version 9.0 and lme4 package of R software were used for analyses. Table 1 describes the study participants. Participants were 51 years of age on average (range 26-82) and were seen by one of five breast surgeons (three males, two females). Most participants were White, Not Hispanic (76%) and more than half (56%) did not have a college degree. Forty-six (61%) were facing cancer treatment decisions and 29 (39%) were facing cancer prevention decisions. Forty-one patients (55%) reported being highly satisfied with their decisions (decision satisfaction >5). Eleven patients (15%) chose options that were inconsistent with their physiciansÕ recommendation. When presented with more than one treatment option, 22 patients (31%) chose the less aggressive option and 27 (38%) chose the more aggressive option. Table 2 summarizes these findings. When we explored these relationships among cancer patients (N = 46), physician communication of uncertainty was negatively related to decision satisfaction (b = )1.77, P < 0.002); cancer patients reported less decision satisfaction when physicians communicated more scientific uncertainty about options. Additionally, there was an interaction effect between total involvement in decision making and communication of uncertainty in relation to cancer patientsÕ decision satisfaction (b = 2.42, P < 0.03). Cancer patients of physicians who involved them more in the decisions were less dissatisfied when presented with information about uncertainty than those whose physicians involved them less in the decision.
Results
Study participants
Discussion
To our knowledge, this study is the first to examine the impact of physician communication of scientific uncertainty in a medical setting with patients facing actual health decisions.
Consistent with previous literature on communicating general illness uncertainty (e.g. 8 ), physicians in our study did not frequently communicate scientific uncertainty to patients. Informed decision making suggests that physicians incorporate the best available evidence into patientsÕ personal context and values, and assumes that uncertainty is explicitly discussed with patients. 27 A lack of discussion about scientific uncertainty may undermine the positive effects of shared decision making on patient outcomes such as knowledge, decision satisfaction and decisional conflict. 4 However, our findings show that communication of scientific uncertainty might lead to decision dissatisfaction among women facing cancer treatment decisions; this finding was not found for women facing prevention decisions. Knowledge about scientific uncertainty might add additional anxiety to individuals facing Ôhigh stakesÕ decisions such as those involving cancer decisions. 28 Past literature has found that high levels of anxiety about illness could lead to a diminished ability to understand disease information 29 and to make appropriate treatment choices. These findings amplify the debate about whether decision satisfaction is an appropriate outcome measure of a good decision-making process. Some level of decision dissatisfaction may be inherent to involving patients in decision making and ethically informing them about their choices that are often based on uncertain evidence or risks. Many argue that Ôgood decision qualityÕ should be measured by patientÕs knowledge about options, realistic perceptions the probability of risks and benefits of options, and ⁄ or agreement between patientsÕ preferences for options and their choices. 30, 31 Satisfaction and decisional conflict are strongly related to the decision outcome, and may not reflect the quality of the decision process. 32 Additionally, our findings suggest that physician communication may play a key role in patientsÕ response to decision making and uncertainty. Patients of physicians who involved them in decision-making discussions reported less dissatisfaction than those whose physicians were more paternalistic in their decision communication. These findings are consistent with communication expertsÕ plea for researchers to develop tools or training for physicians and patients to improve communication about decision making (e.g. 33, 34 ). In situations such as those involving uncertainty about cancer treatments, where communicating the unknowns are essential to treatment decision-making, physicians might lessen the impact of uncertainty on patientsÕ distress by involving patients in decisions. These findings should be interpreted cautiously given several study limitations. First, we were not able to audio-tape the patient-physician interactions. Although we had the same trained rater observe and code all consults to reduce the bias across ratings, we were not able to revisit consults and revise the codes. In However, given the small number of clinicians communicating some types of uncertainty, this over-representation could have actually helped us to examine the impact of uncertainty communication on our outcomes. To get a more accurate understanding of decision communication, future studies should audio-record and code the consults using independent raters who have trained in the OPTION scoring system. Second, participants in our study were all women facing a decision about breast health. Some studies have found that women are more likely than men to experience decisional conflict when facing difficult health decisions. 35 Thus studies should examine uncertainty communication and decision satisfaction among men and ⁄ or women facing a broader range of health decisions. Third, we used a 1-item measure of decision satisfaction (e.g. 16 ) to reduce the length of the questionnaire and participant burden. We also used a subjective scale to measure numeracy that is correlated with objective numeracy and reduces participant burden, but is not a perfect substitution for objective numeracy. Future studies could examine these findings using other measures of decision satisfaction (e.g. 16 ) or an objective measure of numeracy (e.g. 36 ).
To support informed decision making, patientsÕ unique characteristics, circumstances and values need to be considered. Without an explicit discussion of the scientific uncertainty that complicates many decisions, informed decision making may fall short of its goals. As many patients face decisions that are outside the research evidence base, 6 it is essential that research examines the impact of communicating scientific uncertainty to patients. Communicating uncertainty should be studied in relation to overall communication and patient-physician trust 9, 27 to explore whether physician variables such as their tolerance of uncertainty or the patient-physician relationship can lessen any potential negative impact of uncertainty communication and help patients to manage the uncertainty that is inherent in many health decisions.
